Tilmann Todenhofer

Nurtingen, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Nivolumab plus docetaxel versus placebo plus docetaxel for androgen receptor pathway inhibitor-pretreated and chemotherapy-naive metastatic castration-resistant prostate cancer (CheckMate 7DX): a double-blind, randomised, phase 3 trial.

Nivolumab plus docetaxel versus placebo plus docetaxel for androgen receptor pathway inhibitor-pretreated and chemotherapy-naive metastatic castration-resistant prostate cancer (CheckMate 7DX): a double-blind, randomised, phase 3 trial.

Journal: The Lancet. Oncology
Published: April 09, 2025

Nivolumab plus docetaxel versus placebo plus docetaxel for androgen receptor pathway inhibitor-pretreated and chemotherapy-naive metastatic castration-resistant prostate cancer (CheckMate 7DX): a double-blind, randomised, phase 3 trial.

Nivolumab plus docetaxel versus placebo plus docetaxel for androgen receptor pathway inhibitor-pretreated and chemotherapy-naive metastatic castration-resistant prostate cancer (CheckMate 7DX): a double-blind, randomised, phase 3 trial.

Journal: The Lancet. Oncology
Published: April 09, 2025

An IgG-based bispecific antibody for improved dual targeting in PSMA-positive cancer.

An IgG-based bispecific antibody for improved dual targeting in PSMA-positive cancer.

Journal: EMBO molecular medicine
Published: December 13, 2019

A Subpopulation of Stromal Cells Controls Cancer Cell Homing to the Bone Marrow.

A Subpopulation of Stromal Cells Controls Cancer Cell Homing to the Bone Marrow.

Journal: Cancer research
Published: December 30, 2016

Microhematuria assessment an IBCN consensus-Based upon a critical review of current guidelines.

Microhematuria assessment an IBCN consensus-Based upon a critical review of current guidelines.

Journal: Urologic oncology
Published: February 29, 2016

Is there an anti-androgen withdrawal syndrome for enzalutamide?

Is there an anti-androgen withdrawal syndrome for enzalutamide?

Journal: World journal of urology
Published: February 13, 2014

Considerations on the use of urine markers in the management of patients with high-grade non-muscle-invasive bladder cancer.

Considerations on the use of urine markers in the management of patients with high-grade non-muscle-invasive bladder cancer.

Journal: Urologic oncology
Published: February 01, 2014

Bladder cancer discussed on the internet: a systematic analysis of gender differences of initial posters on an online discussion board.

Bladder cancer discussed on the internet: a systematic analysis of gender differences of initial posters on an online discussion board.

Journal: SpringerPlus
Published: June 01, 2013
Showing 1-8 of 8

Last Updated: 09/26/2026